Jonathan C Fox, President and Chief Medical Officer at Eidos Therapeutics, holds 23.70K shares in Edgewise Therapeutics (Ticker: EWTX), holds 380.97K shares in Eidos Therapeutics (Ticker: EIDX). Most recently, Jonathan C Fox Bought ― shares of Edgewise Therapeutics on Nov 13, 2025 for an estimated value of $199.34K.
What is the percentage of profitable transactions made by Jonathan C Fox?
The percentage of profitable transactions made by Jonathan C Fox is 9%.
What is the average return per transaction made by Jonathan C Fox?
The average return per transaction made by Jonathan C Fox is -51.50%.
What stocks does Jonathan C Fox hold?
Jonathan C Fox holds: EIDX, EWTX stocks.
What was Jonathan C Fox’s latest transaction?
Jonathan C Fox latest transaction was an Informative Buy of $199.34K.
What was Jonathan C Fox's most profitable transaction?
Jonathan C Fox’s most profitable transaction was an Informative Buy of EWTX stock on December 28, 2023. The return on the trade was 149.90%.
What is Jonathan C Fox's role in Eidos Therapeutics?
Jonathan C Fox's role in Eidos Therapeutics is President and Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.